Want to join the conversation?
$VAR posted 1Q16 GAAP net earnings of $89MM or $0.91 per diluted share, down nearly 5% compared to GAAP net earnings of $93.3MM in 1Q15. $VAR's revenues totaled $757MM, up 3% from the year-ago quarter. The company ended the quarter with a $3.3Bil backlog, up 7% from the end of the first quarter of FY15.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.